Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.
Clinical trial NCT06851819 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06851819
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-01-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.